Related Experiment Videos
Recent advances in parapneumonic effusion and empyema
Stephen J Chapman1, Robert J O Davies
1Oxford Pleural Diseases Unit, Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK. schapman@well.ox.ac.uk
Current Opinion in Pulmonary Medicine
|June 29, 2004
Summary
Recent advances in managing complicated parapneumonic effusion and empyema offer new insights into pathogenesis and treatment. Further research is needed to clarify the roles of intrapleural fibrinolytics and surgical timing for optimal patient outcomes.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Thoracic Surgery
Background:
- Complicated parapneumonic effusion and empyema are significant causes of morbidity and mortality.
- Optimal management strategies for these pleural infections remain an area of active investigation.
Purpose of the Study:
- To review recent advancements in understanding and managing complicated parapneumonic effusion and empyema.
- To identify key areas for future research in pleural infection.
Main Methods:
- Literature review of recent studies on pleural infection.
- Analysis of advances in pathogenesis, bacteriology, and treatment of empyema.
Main Results:
- Advances in understanding empyema pathogenesis, including inflammatory and coagulation cascades.
- Clarification of empyema bacteriology, differentiating community- vs. hospital-acquired infections.
- Focus on intrapleural fibrinolytics and surgical interventions in treatment studies.
Conclusions:
- Enhanced understanding of empyema pathogenesis may lead to novel therapeutic targets.
- Detailed bacteriology aids antibiotic selection; intrapleural DNase shows promise for fluid drainage.
- Uncertainties persist regarding intrapleural fibrinolytics and optimal surgical timing.